Gary Bourgeault
Long only, research analyst, portfolio strategy, media

Short Term And Long-Term Catalysts That Will Drive Mesa Laboratories Further Up

An unusual earnings report that revealed its usually predictable and profitable Biological Indicators division had underperformed, resulted in Mesa Laboratories (NASDAQ:MLAB) taking a big hit over a three-day period, dropping from $67.33 on August 6, 2013 to $58.79 on the close of trading on August 9, 2013.

As the anomaly was understood by investors, the share price started to rebound, already soaring almost 5% on Monday, August 12, 2013, to close at $61.63 per share. Having dropped just under 14%, there is still a lot of upside in the near term, and over the long term will continue on its upward run.

With the incident leading to the miss in the latest quarter having already been taken care...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details